Price
No data yet.
Social Signal Score
Analyst Ratings
21 analystsRevenue
$587.30M+147.78%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Matitiahu Shem Tov
- Sector
- Technology
- Industry
- Information Technology Services
- Employees
- 12,000
- Beta
- 1.40
- Country
- GB
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- -0.76
Financials
Revenue
$587.30M+147.8%Net Income
$-268.60MEBITDA
$-14.50M-214.7%Free Cash Flow
$44.00M+75.2%EPS (diluted)
$-0.42Shares Outstanding (diluted)
639.40M+109.5%Operating Expenses
$181.60MCash & Debt
$217.70MReturn of Capital
$1.30MRevenue by Segment (annual)
$4.08BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.46B | $-201.10M | $-0.30 |
| 2024 | $2.56B | $-636.70M | $-0.96 |
| 2023 | $2.63B | $-911.20M | $-1.47 |
| 2022 | $2.66B | $-3.96B | $-6.26 |
| 2021 | $1.88B | $-270.50M | $-0.62 |
| 2020 | $1.25B | $-350.60M | $-0.63 |
| 2019 | $974.35M | $-258.63M | $-0.39 |
| 2018 | $968.47M | $-242.16M | $-0.79 |
| 2017 | $917.63M | $-263.93M | $-0.86 |
Valuation
CLVThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (8)
- Newsbusinesswire.com·1d ago·Neutral
…essler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, to develop AI-enhanced patent workflow solutions. This partnership brings together Sterne Kessler's practitioner-built technology and deep patent practice expertise with Clarivate's leading IP data and software. Together, the.
View source ↗ - Newsprnewswire.com·10d ago·Neutral
…ment and Intellectual Property segments Proceeds strengthen balance sheet and enhance financial flexibility LONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the successful completion of the sale of its Life Sciences & Healthcare segment to Altaris, LLC ("Altaris"), advancing Clarivate's transformation and simplifying its portfolio. The transaction for $600 million was previous…
View source ↗ - Newsprnewswire.com·22d ago·Negative
…larivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding 3.875% Senior Secured Notes du…
View source ↗ - Newsprnewswire.com·23d ago·Neutral
…larivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (th…
View source ↗ - Newsprnewswire.com·24d ago·Neutral
Clarivate to Report Third Quarter 2026 Results on November 3, 2026 LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third quarter 2026 before the market opens on Tuesday, November 3, 2026.
View source ↗ - Newsgurufocus.com·29d ago·Negative
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific BreakthroughsPR NewswireLONDON, Sept. 17, 202622 researchers honored for Nobel-c
View source ↗ - Newsprnewswire.com·29d ago·Negative
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs 22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the Citation Laureates 2026, a distinguished group of 22 researchers whose work is of Nobel class.
View source ↗ - Newsglobenewswire.com·45d ago·Negative
Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member Veteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise to Support Accuserve's Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Accuserve Solutions (“Accuserve” or the “Company”), an independent managed repair services platform connecting insurance carriers, homeowners, and contractors, today announced the appointment of Maroun S
View source ↗
Earnings
Tue, Nov 3(in 2 weeks)
Consensus estimate $0.18 per share
Typical surprise +12.5% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$0.19 vs $0.18beat
- Wed, Apr 29$0.18 vs $0.14beat
- Tue, Feb 24$0.20 vs $0.16beat
- Wed, Oct 29$0.18 vs $0.16beat
- Wed, Jul 30$0.18 vs $0.18beat
- Tue, Apr 29$0.14 vs $0.12beat
Estimates and results for CLVT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CLVT officers and directors.
- Bought
- $9.4m
- Sold
- $6.0m
6 trades
4 trades
- Cornick Kenneth L.bought
- Cornick Kenneth L.bought
- Snyder Andrew Milessold
- Snyder Andrew Milessold
- Snyder Andrew Milessold
- Veinstein Barsold
- Cornick Kenneth L.bought
- Cornick Kenneth L.bought
90 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (32d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Dec 29, 2022 (29d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.